Alternative treatment strategies using anti-wolbachial drugs to accelerate elimination of onchocerciasis and lymphatic filariasis, funded by European and Developing Countries Clinical Trial partnership (EDCTP), 2020-2024, Amount :€499,888

Tackling the Obstacles to fight Filariasis and Podoconiosis (TAKeOFF), German Ministry of Education and Research (BMBF), 2017-2021, Amount: €2.8 million

Capacity Building for Early Career Researchers, funded by German Ministry of Education and Research (BMBF), 2019-2020, Amount: 

€30,000

Mansonella perstans effects on BCG vaccine-induced protection against childhood tuberculosis (TB) as well as TB disease severity and recovery in Ghana and Cameroon (MapTB), German Research Foundation (DFG), 2018-2021, Amount: €411,310

Dissecting the effects of filarial-associated immunomodulation on HIV susceptibility, Risk for HIV Infection through Nematodes, German Research Foundation (DFG), 2018-2021, Amount: €307,222

AREF Excell Researcher and Leadership Development Programme award to train postdocs on research communication skills (Grants 1 and 2), Robert Bosch Stiftung Foundation, 2018-2020, Amount: €30,000

The efficacy of Rifapentine plus Moxifloxacin against Onchocerciasis, funded by University of Bonn, Germany, 2017-2020, Amount: €250,000

Rapid diagnosis of onchocerciasis using urinary biomarkers, funded by British Medical Research Council, 2017-2019, Amount: £24,055

First Stage Genome Scan Association Study, funded by German Research Foundation (DFG), 2016-2019, Amount: €418,560

Death to Onchocerciasis and lymphatic filariasis: Comparison of Ivermectin alone with Albendazole plus Ivermectin in their Efficacy Against Onchocerciasis, funded by Bill and Melinda Gates Foundation through Case Western University, Ohi, USA, 2012-2017, Amount: $1.1 million

The effects of Mansonella perstans infection on concomitant mycobacterial  infections and BCG-vaccination efficacy in Ghana, Benin and Cameroon (Map2Co), funded by German Research Foundation (DFG), 2015-2018, Amount: €545,667

Analysis of genetic polymorphisms of cytokines, vascular endothelial growth factors (VEGFs) and VEGF receptors in disease manifestations in lymphatic filariasis (Junior fellowship), funded European Foundation Initiative for NTDs( EFINTD), 2008-2011, Amount: €100,000

Analysis of genetic polymorphisms of cytokines, vascular endothelial growth factors (VEGFs) and VEGF receptors in disease manifestations in lymphatic filariasis (Senior fellowship), funded European Foundation Initiative for NTDs (EFINTD), 2011-2014, Amount: €150,000 

Genetics of Lymphoedema and Hydrocele (Phase 1 and 2), funded German Research Foundation (DFG), 2015-2018, Amount: €545,667

Enhanced Protective Immunity Against Filariasis, funded by European Commissions, 2010-2014, Amount: €275,400

Wolbachia endobacteria in filarial infections – exploring their usefulness as targets for novel chemotherapies that are anti-filarial, reduce filarial pathology and interrupt transmission, funded VW Foundation of Germany, 2007-2010, Amount: €302,000

Anti-wolbachia treatment of filarisis (AWOL), funded by Bill and Melinda Gates Foundation, 2007-2015, Amount: $1.2 million

In vitro assessment of a non-invasive biomarkers for the diagnosis of onchocerciasis, funded Janssen Diagnostics BVB, 2015-2017, Amount: €40,644

Establishment of German-West African Centre for Global Health and Pandemic Prevention. Establishment and training of staff against future pandemic. funded by German Academic Exchange Service (DAAD); Amount €2.5million; 2021-2025

Tackling the Obstacles of Filariasis and Podoconiosis Disease Control (TAKeOFF II), Funded German Ministry for Research and Education (BMBF) Amount: 2.1 million Euros; 2023-2027